I agree totally. RMD are leaders in the technology, and now the litigation by competition, has been
settled, the only way is up. Given(IMHO), the AUD will go under .70 cents, that only increases
the returns to RMD. Everyone doubted Cochlear....no need to say anymore.
- Forums
- ASX - By Stock
- RMD
- ResMed in Numbers - Highlights from its Q4 of FY2018
ResMed in Numbers - Highlights from its Q4 of FY2018, page-20
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$36.04 |
Change
-0.620(1.69%) |
Mkt cap ! $22.01B |
Open | High | Low | Value | Volume |
$35.95 | $36.08 | $35.49 | $58.29M | 1.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 27 | $35.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$36.05 | 12289 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27 | 35.960 |
1 | 15 | 35.950 |
1 | 576 | 35.940 |
1 | 750 | 35.900 |
1 | 19 | 35.810 |
Price($) | Vol. | No. |
---|---|---|
36.050 | 200 | 1 |
36.060 | 700 | 1 |
36.100 | 549 | 2 |
36.500 | 200 | 1 |
36.570 | 280 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online